What is the price target for ACH stock?
12 analysts have analysed ACH and the average price target is 3.32 USD. This implies a price decrease of -13.45% is expected in the next year compared to the current price of 3.83.
ACCENDRA HEALTH INC (ACH) Forecast, Price Target & Analyst Ratings
NYSE:ACH • US6907321029
Current stock price
3.83 USD
+0.41 (+11.99%)
At close:
3.8104 USD
-0.02 (-0.51%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ACCENDRA HEALTH INC (ACH).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 1, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.10
- Revenue Estimate
- 651.08M
Price Target Details & History
Consensus Price Target and Range
Mean target
$3.32
Upside
-13.45%
From current price of $3.83 to mean target of $3.32, Based on 12 analyst forecasts
Low
$2.27
Median
$3.06
High
$5.25
Price Target Revisions
1 Month
0.00%
3 Months
-12.16%
Price Target Summary
12 Wall Street analysts provided a forecast for the next 12 months for ACH. The average price target is 3.32 USD. This implies a price decrease of -13.45% is expected in the next year compared to the current price of 3.83.
The average price target has been revised downward by 12.16% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
50.00%
ACH was analyzed by 12 analysts. The buy percentage consensus is at 50. So analysts seem to be rather neutral about ACH.
In the previous month the buy percentage consensus was at a similar level.
ACH was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-20 | Leerink Partners | Maintains | Market Perform -> Market Perform |
| 2026-01-09 | Citigroup | Maintains | Buy -> Buy |
| 2022-08-25 | Goldman Sachs | Upgrade | Sell -> Neutral |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 1, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.10
- Revenue Estimate
- 651.08M
- Revenue Q2Q
- -75.26%
- EPS Q2Q
- -144.50%
- Number of Analysts
- 7
Next Earnings Revisions
Revenue (1 Month)
-0.27%
Revenue (3 Months)
-0.45%
EPS (1 Month)
8.02%
EPS (3 Months)
-169.64%
Next Earnings Summary
ACH is expected to report earnings on 5/1/2026. The consensus EPS estimate for the next earnings is -0.1 USD and the consensus revenue estimate is 651.08M USD.
The next earnings revenue estimate has been revised downward by 0.45% in the past 3 months.
Full Analyst Estimates 2026 - 2030
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.553B -74.36% | 2.68B 5.00% | 2.762B 3.06% | 2.616B -5.29% | 2.732B 4.43% | 2.889B 5.75% | 3.251B 12.53% | N/A | |
| EBITDA YoY % growth | 502.741M 17.85% | 400.985M -20.24% | 340.453M -15.10% | 342.01M 0.46% | 374.59M 9.53% | 396.59M 5.87% | N/A | N/A | |
| EBIT YoY % growth | 215.364M 8.81% | 136.21M -36.75% | 125.929M -7.55% | 193.48M 53.64% | 229.82M 18.78% | 244.87M 6.55% | N/A | N/A | |
| Operating Margin | 8.44% | 5.08% | 4.56% | 7.40% | 8.41% | 8.48% | N/A | N/A | |
| EPS YoY % growth | 1.36 -43.57% | 1.52 11.76% | 0.95 -37.50% | 0.68 -28.93% | 1.05 55.57% | 1.23 16.63% | 1.27 3.46% | 1.65 29.88% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.10 -144.50% | 0.10 -60.89% | 0.27 6.32% | 0.41 95.27% | 0.16 257.90% | 0.26 158.27% | 0.32 21.59% | 0.51 23.15% | 0.24 50.00% | 0.29 11.54% | 0.36 12.50% | 0.57 12.00% |
| Revenue Q2Q % growth | 651.08M -75.26% | 636.34M -6.68% | 657.38M -5.72% | 673.06M -5.06% | 667.92M 2.59% | 657.18M 3.27% | 674.49M 2.60% | 689.59M 2.46% | 732.36M 9.65% | 699.06M 6.37% | 714.54M 5.94% | 732.32M 6.20% |
| EBITDA Q2Q % growth | 58.253M -46.45% | 77.96M -54.08% | 94.482M -55.39% | 111.14M -48.33% | 80.083M 37.47% | 91.072M 16.82% | 98.551M 4.31% | 118.95M 7.03% | 89.617M 11.91% | 95.576M 4.95% | 103.26M 4.78% | 126.68M 6.50% |
| EBIT Q2Q % growth | 22.277M -53.22% | 42.686M -13.29% | 59.266M 118.45% | 75.501M 13,577.72% | 46.445M 108.49% | 57.333M 34.31% | 64.766M 9.28% | 85.158M 12.79% | 53.964M 16.19% | 59.913M 4.50% | 67.599M 4.37% | 91.031M 6.90% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
8.85%
EPS Next 5 Year
11.62%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
1.08%
Revenue Next 5 Year
3.83%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
19.83%
EBIT Next 5 Year
N/A
ACCENDRA HEALTH INC / ACH Forecast FAQ
When does ACCENDRA HEALTH INC (ACH) report earnings?
ACCENDRA HEALTH INC (ACH) will report earnings on 2026-05-01, before the market open.
Can you provide the consensus estimates for ACCENDRA HEALTH INC next earnings?
The consensus EPS estimate for the next earnings of ACCENDRA HEALTH INC (ACH) is -0.1 USD and the consensus revenue estimate is 651.08M USD.
What is the expected long term growth rate for ACH stock?
The expected long term growth rate for ACCENDRA HEALTH INC (ACH) is 1.08%.